what are side effects of semaglutide injections Ozempic | Ozempic type 2 diabetes injection 7 Risks of Semaglutide Side

Johnson & Johnson

And the honest answer is: what you eat on GLP-1 therapy matters more than most people realize

Alexander Kokkinos Carel Le Roux To view or add a comment, sign in Tirzepatide: Redefining Outcomes in Diabetes & Obesity Care Clinical trials show tirzepatide, a dual GIP/GLP-1 receptor agonist, is delivering results beyond expectations: Up to 20.9% mean weight loss at 72 weeks (SURMOUNT-1, NEJM) 94% risk reduction in progression from prediabetes to type 2 diabetes over 3 years Superior HbA1c reduction and weight control vs leading GLP-1 therapies (SURPASS program) With manageable side effects and durable outcomes, tirzepatide is reshaping how we approach metabolic disease

Prez-Gutirrez AM, et al